Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neuroscience Letters|February 23, 1999
19/20 kDa low molecular weight serum protein pattern: a novel potential biochemical prognostic marker for different types of dementiaV R Lombardi, R Cacabelos
Journal of Neuroscience Research|November 20, 1998
Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypesV R Lombardi, M García, R Cacabelos
Methods and Findings in Experimental and Clinical Pharmacology|August 14, 1998
APOE-induced microglial activation: an in vitro assay to screen sera from Alzheimer's disease patients and novel therapeutic compoundsV R Lombardi, M García, R Cacabelow
Journal of Neuroimmunology|July 17, 1999
Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individualsV R Lombardi, M García, L Rey, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 27, 1999
Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell culturesV R Lombardi, M Windisch, M García, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1997
An experimental model to study the cytotoxic effects induced by beta-amyloid, histamine, LPS and serum from Alzheimer patients on cultured rat endothelial cellsE Maneiro, V R Lombardi, R Lagares, et al.
Acta Neurologica Scandinavica. Supplementum|March 23, 2001
A pharmacogenomic approach to Alzheimer's diseaseR Cacabelos, A Alvarez, L Fenández-Novoa, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1986
Distinct appearance of differentiation markers in HL60 cell line treated with 1,25 dihydroxyvitamin D3 and phorbol esters (TPA)L Chini, E Galli, V R Lombardi, et al.
Clinical Immunology and Immunopathology|August 1, 1997
The presence of antibodies against HIV peptides in the sera of alloimmune mice and thalassemic patients is due to a polyclonal activation mechanismM Fraziano, C Montesano, V R Lombardi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 22, 2001
Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's diseaseA C Allison, R Cacabelos, V R Lombardi, et al.
Pageof 2